Thiobenzoic Acid

Thiobenzoic Acid

SCHEMBL284149

OC(=S)c1ccccc1.[KH]

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.48
MAPT P10636 4/20 0.48
L3MBTL1 Q9Y468 2/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 2/20 0.46
KMT2A Q03164 2/20 0.46
HSP90AA1 P07900 1/20 0.46
GAA P10253 1/20 0.46
CES1 P23141 3/20 0.45
CES2 O00748 2/20 0.45
TSHR P16473 2/20 0.45
DAO P14920 1/20 0.45
NAPRT Q6XQN6 1/20 0.45
POLB P06746 2/20 0.41
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
F2 P00734 1/20 0.41
F10 P00742 1/20 0.41
F12 P00748 1/20 0.41
F7 P08709 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Thiobenzoic Acid SCHEMBL2165933 1.00 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL28571983 1.00 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL160729 0.97 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL37018 0.97
Thiobenzoic Acid SCHEMBL15282156 0.97 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL28199536 0.97 ALDH1A1 (0.50) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL11305253 0.93 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL11330586 0.93 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL21806751 0.93 ALDH1A1 (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD
Thiobenzoic Acid SCHEMBL20741485 0.93 MAPT (0.48) ALDH1A1MAPTL3MBTL1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 174 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118894800-A Preparation method of Lefamulin intermediate compound 福建省微生物研究所 2024-11-05 CN claimed
CN-118496133-A Method for synthesizing thioamide compound by using aryl chloride and isonitrile 华南理工大学 2024-08-16 CN claimed
CN-114805384-A Method for preparing D-biotin intermediate 帝斯曼知识产权资产管理有限公司 2022-07-29 CN claimed
CN-104556012-B A kind of sulfhydryl modified graphene oxide and preparation method thereof ZHEJIANG TANGUSHANGXI MATERIAL SCIENCE & TECHNOLOGY CO., LTD. (CN) 2016-04-27 CN claimed
CN-104974295-A High-stability polybenzyl mercaptane and synthetic method thereof NINGBO INST MATERIALS TECHNOLOGY & ENG CAS 2015-10-14 CN claimed
CN-104556012-A Sulfydryl-modified graphene oxide and preparation method thereof ZHEJIANG TANGU SHANGXI MATERIAL TECHNOLOGY CO LTD 2015-04-29 CN claimed
CN-102964286-B Chiral pyrrolidine compound and preparation method thereof SHIJIAZHUANG WANSHANG MEDICAL TECHNOLOGY CO LTD 2014-06-25 CN claimed
CN-102964286-A Chiral pyrrolidine compound and preparation method thereof SHIJIAZHUANG WANSHANG MEDICAL TECHNOLOGY CO LTD 2013-03-13 CN claimed
CN-102702291-A 3'-thionucleoside synthesis method UNIV EAST CHINA SCIENCE & TECH 2012-10-03 CN claimed
US-7122693-B2 Acetaldehyde acetal compounds, their synthesis, and uses thereof SHIRE BIOCHEM INC. (CA) 2006-10-17 US claimed
JP-62230797-A None JP disclosed
CN-116917271-B Process for producing arylthiol ester compound AGC株式会社 2026-05-15 CN disclosed
EP-4496795-B1 PIPERAZINE SUBSTITUTED INDAZOLE COMPOUNDS AS INHIBITORS OF PARG IDEAYA BIOSCIENCES INC (US) 2026-04-01 EP disclosed
EP-4687894-A1 COMBINATION THERAPY COMPRISING A PARG INHIBITOR AND A TOPOISOMERASE INHIBITOR FOR TREATING CANCER Ideaya Biosciences, Inc. (US) 2026-02-11 EP disclosed
US-20250376467-A1 PIPERAZINE SUBSTITUTED INDAZOLE COMPOUNDS AS INHIBITORS OF PARG IDEAYA BIOSCIENCES INC (US) 2025-12-11 US disclosed
US-4119717-A STEROIDS, ANTIMICROBIAL AGENTS LEO PHARMACEUTICAL PRODUCTS LTD. A/S LOVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB (DK) 1978-10-10 US disclosed
US-4061759-A ANTIINFLAMMATORY, ARTHRITIS MERCK & CO., INC. (US) 1977-12-06 US disclosed
US-4053606-A ANTIINFLAMMATORY AND ANTIARTHRITIC AGENTS MERCK & CO., INC. (US) 1977-10-11 US disclosed
US-4041015-A LINEAR METAL POLYSULFIDES M&T CHEMICALS INC. (US) 1977-08-09 US disclosed
US-4039536-A 7-(α-SUBSTITUTED GLYCINAMIDO)-3-SUBSTITUTED METHYL-3-CEPHEM-4-CARBOXYLIC ACIDS AND THEIR DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JA) 1977-08-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250376467-A1 PIPERAZINE SUBSTITUTED INDAZOLE COMPOUNDS AS INHIBITORS OF PARG PARG, PARP15, PARP11 ALDH1A1 563/4885MAPT 1856/4885L3MBTL1 4204/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.